Aarti Industries has entered into a multi-year supply agreement with a top global agrochemical innovator for the supply of a critical agrochemical intermediate used in crop protection formulations. This agreement elevates the current annual engagement to a structured supply contract through March 31, 2030, with a significant increase in volumes. The agreement is expected to generate revenue of around $150 million over the contract period, providing the company with enhanced revenue visibility in the medium to long term.
Under the terms of the agreement, the company will manufacture and supply the intermediate, leveraging its integrated, scalable manufacturing platform, deep process chemistry expertise, and established global regulatory compliance framework. It has adequate capacities to meet this requirement and thus this contract supports the company to attain higher capacity utilisation and volumes without incremental capex. The intermediate will be used by the customer in the manufacturing and formulation of crop-protection products for global agricultural markets.
This collaboration reinforces the company’s position as a trusted strategic partner for global agrochemical innovators, strengthening its participation in high-value, long-term speciality chemical supply chains. By leveraging its strong process development capabilities and manufacturing infrastructure, it continues to strengthen its role in supporting the global agriculture ecosystem.
Aarti Industries (AIL) is a leading Indian manufacturer of speciality chemicals and pharmaceuticals with a global footprint.
| Company Name | CMP |
|---|---|
| BASF India | 3640.10 |
| Tata Chemicals | 809.45 |
| SRF | 2519.20 |
| Pidilite Inds. | 1375.55 |
| Deepak Nitrite | 1736.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: